Parallel Bio specializes in drug discovery and development using immune organoids and artificial intelligence within the pharmaceutical sector. The company offers services that include predicting drug safety, modelling diseases and discovering new drug targets, all leveraging human immune system replicas and advanced technology. Parallel Bio primarily serves the pharmaceutical and biotechnology industries.